NephroNet

Call Website

NephroNet Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from NephroNet, Market Research Consultant, Lawrenceville, GA.

NephroNet is a network of dedicated clinicians, investigators and affiliated sponsors that are collectively committed to advancing patient education, research and the realization of new methods to treat kidney disease.

We're excited to be heading to ASN 2026 and can't wait to reconnect with familiar faces, make new connections, and share...
10/13/2026

We're excited to be heading to ASN 2026 and can't wait to reconnect with familiar faces, make new connections, and share what we've been working on!

📍 Stop by Booth #361 to say hello. We'd love to see you!

🧠✨ A new nanomedicine approach to calm the immune system.Researchers have developed cationic lipid-modified PEG-PLGA nan...
10/11/2026

🧠✨ A new nanomedicine approach to calm the immune system.
Researchers have developed cationic lipid-modified PEG-PLGA nanoparticles (CLAN) that precisely deliver dual siRNAs to dendritic cells — reprogramming them to restore immune balance and reduce inflammation in autoimmune disease.
🔬 In an experimental autoimmune encephalomyelitis (EAE) model (a multiple sclerosis equivalent), this approach:
✅ Silenced key immune activation genes (CD40 & LKB1)
✅ Reduced Th1/Th17 inflammation
✅ Promoted regulatory T cell (Treg) activity
✅ Protected spinal cord tissue from damage
💡 Takeaway: CLAN nanoparticles represent a promising tool for retraining the immune system and tackling diseases like multiple sclerosis at their cellular roots.

https://pubmed.ncbi.nlm.nih.gov/41124812/

Chronic Kidney Disease (CKD) in Indonesia: An Urgent Health PriorityA new multicentre study across 14 primary care centr...
10/08/2026

Chronic Kidney Disease (CKD) in Indonesia: An Urgent Health Priority
A new multicentre study across 14 primary care centres in Jakarta found that 1 in 7 people with diabetes or hypertension already have CKD — and nearly half are at moderate to very high risk of kidney complications, even when kidney function appears normal.
📊 Key insights:
🔹 CKD prevalence: 14.8%
🔹 Annual eGFR decline: 4.7 mL/min/1.73 m²
🔹 Risk factors: older age, male s*x, albuminuria, haematuria, and cardiovascular disease
🔹 Number needed to screen: 7 patients to find 1 CKD case
💡 Takeaway: Early kidney screening among people with diabetes and hypertension is critical to preventing irreversible kidney damage and improving outcomes.

https://pubmed.ncbi.nlm.nih.gov/41125263/

⚖️ Weight matters — even in Type 1 diabetes.A nationwide Japanese study (J-DREAMS) found that overweight adults (BMI ≥ 2...
10/05/2026

⚖️ Weight matters — even in Type 1 diabetes.
A nationwide Japanese study (J-DREAMS) found that overweight adults (BMI ≥ 25 kg/m²) with Type 1 diabetes were more than twice as likely to develop coronary artery disease (CAD) compared to those with lower BMI.
📊 Key findings:
🔹 CAD prevalence: 8.9% in overweight vs. 3.4% in non-overweight
🔹 Overweight linked with neuropathy, nephropathy, hypertension, and dyslipidemia
🔹 Those overweight at age 20 had higher current BMI, HbA1c, and cardiovascular risk
💡 Takeaway: Early and consistent weight management is crucial in Type 1 diabetes to protect heart and kidney health long-term.

https://pubmed.ncbi.nlm.nih.gov/41125203/

💉 Endothelial health holds the key to understanding diabetic complications.A new study reveals that lower serum adropin ...
10/02/2026

💉 Endothelial health holds the key to understanding diabetic complications.
A new study reveals that lower serum adropin and higher miR-21 expression are strongly linked to endothelial dysfunction in patients with Type 2 diabetes mellitus (T2DM).
🩸 Compared to healthy individuals, people with T2DM — especially those with macrovascular or microvascular complications — showed:
🔹 Significantly lower adropin levels (a peptide that supports metabolic balance)
🔹 Significantly higher miR-21 expression, which correlates with vascular injury
💡 Takeaway: Monitoring adropin and miR-21 may help identify early endothelial damage and predict vascular complications in diabetes.

https://pubmed.ncbi.nlm.nih.gov/41125677/

🧬 New insights into IgA nephropathy pathogenesisWhile B Cell Activating Factor (BAFF) has long been considered a possibl...
09/28/2026

🧬 New insights into IgA nephropathy pathogenesis
While B Cell Activating Factor (BAFF) has long been considered a possible driver of IgA overproduction, new evidence suggests otherwise.
In a murine IgA nephropathy model, researchers found that blocking BAFF lowered total immunoglobulin levels but did not affect aberrantly glycosylated IgA, immune complex formation, or glomerular injury.
💡 Takeaway: BAFF inhibition alone may not alter the production of nephritogenic IgA, highlighting the need for more targeted pathways in IgAN therapy.

https://pubmed.ncbi.nlm.nih.gov/41093370/

🧬 Understanding Glomerulonephritis in Autoimmune DiseaseGlomerulonephritis (GN) develops when the immune system mistaken...
09/24/2026

🧬 Understanding Glomerulonephritis in Autoimmune Disease
Glomerulonephritis (GN) develops when the immune system mistakenly targets the kidneys — a complex interplay of antibodies, immune cells, and complement activation.
This new review unites findings from biopsy-based pathology, multiomics, and spatial profiling to reveal how lupus nephritis, IgA nephropathy, and ANCA-associated vasculitis share common injury pathways:
💥 Complement activation
🧫 Fc receptor–driven inflammation
🧬 IL-23/IL-17 and type I interferon responses
💡 Takeaway: Though autoimmune GNs begin differently, they converge on shared, targetable mechanisms — paving the way for personalized, pathway-aligned therapy.

https://pubmed.ncbi.nlm.nih.gov/41133475/

🥼 Metabolic health meets kidney survival.A new study reveals that a higher Cholesterol-HDL-Glucose (CHG) index, a marker...
09/22/2026

🥼 Metabolic health meets kidney survival.
A new study reveals that a higher Cholesterol-HDL-Glucose (CHG) index, a marker of insulin resistance and metabolic imbalance, is strongly linked to poorer kidney outcomes in patients with IgA nephropathy (IgAN).
📊 In a study of 1,791 biopsy-proven IgAN patients, those with a CHG index > 5.29 had an 84% higher risk of adverse renal outcomes — even after adjusting for other clinical factors.
💡 Takeaway: The CHG index could become a simple, accessible tool to identify patients at risk for faster kidney decline, highlighting the connection between metabolic health and renal survival.

https://pubmed.ncbi.nlm.nih.gov/41103652/

🧠 New insight into IgA nephropathy and inflammation.In a real-world study of over 1,000 patients, researchers found that...
09/17/2026

🧠 New insight into IgA nephropathy and inflammation.
In a real-world study of over 1,000 patients, researchers found that a higher neutrophil-to-lymphocyte ratio (NLR) — an indicator of systemic inflammation — was strongly linked to early kidney function decline (eGFR ≤ 60 mL/min/1.73 m²).
🔬 Elevated NLR correlated with worse clinical features including higher proteinuria, uric acid, and blood pressure — and lower hemoglobin and albumin.
💡 Takeaway: NLR may serve as a simple, accessible biomarker to help predict renal outcomes in IgA nephropathy.

https://pubmed.ncbi.nlm.nih.gov/41131907/

📈 Redefining prognosis in childhood-onset lupus nephritis (cLN)A recent study found that tubulointerstitial lesions—espe...
09/14/2026

📈 Redefining prognosis in childhood-onset lupus nephritis (cLN)
A recent study found that tubulointerstitial lesions—especially tubular atrophy—predict kidney function decline more strongly than glomerular changes or activity scores.
The NIH-modified chronicity index (CI) emerged as a reliable prognostic tool, and maintenance therapy with mycophenolate mofetil (MMF) was linked to improved kidney outcomes.
🔍 These findings underscore the value of chronic lesion assessment and optimized therapy to improve long-term outcomes in pediatric lupus nephritis.

https://pubmed.ncbi.nlm.nih.gov/41132094/

Address

Lawrenceville, GA

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+17704909203

Alerts

Be the first to know and let us send you an email when NephroNet posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share